Fulgent Genetics (FLGT) Change in Acquisitions & Divestments (2017 - 2026)

Fulgent Genetics has disclosed Change in Acquisitions & Divestments across 10 years of filings, most recently posting $21.5 million for Q2 2026.

• In Q2 2026, Change in Acquisitions & Divestments fell 64.28% year-over-year to $21.5 million; the TTM figure through Jun 2026 stood at $221.6 million (down 21.54% YoY), while the FY2025 annual figure was $211.0 million, down 39.68% from the prior year.
• Change in Acquisitions & Divestments came in at $21.5 million for Q2 2026 at Fulgent Genetics, down from $81.7 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $141.4 million in Q1 2023 to a low of $21.5 million in Q2 2026.
• Average Change in Acquisitions & Divestments over 5 years is $78.1 million, with a median of $74.9 million recorded in 2024.
• Year-over-year, Change in Acquisitions & Divestments soared 409.39% in 2023 and tumbled 66.01% in 2025.
• Over 5 years, Change in Acquisitions & Divestments stood at $100.8 million in 2022, then jumped by 30.6% to $131.7 million in 2023, then slumped by 45.48% to $71.8 million in 2024, then gained by 8.79% to $78.1 million in 2025, then tumbled by 72.45% to $21.5 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $21.5 million in Q2 2026, $81.7 million in Q1 2026, and $78.1 million in Q4 2025.